Kevin E. Chan

发表

Racial/Ethnic Disparities in Atrial Fibrillation Treatment and Outcomes among Dialysis Patients in the United States.

Jenna M. Norton, P. Kimmel, P. Eggers, 2020, Journal of the American Society of Nephrology : JASN.

Early outcomes among those initiating chronic dialysis in the United States.

R. Thadhani, R. Hakim, N. Tolkoff-Rubin, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Warfarin, Atrial Fibrillation, and CKD: Effective and Safe, but Soon Extinct?

J. Larkin, Kevin E. Chan, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Baseline Characteristics of Patients Initiated on Warfarin , Aspirin , Dabigatran , or Rivaroxaban Aspirin Dabigatran Rivaroxaban Warfarin Aspirin

E. Edelman, R. Thadhani, J. Wenger, 2015 .

Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.

Chiayu Lin, Xiao-hong Fan, Sahir Kalim, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Adherence barriers to chronic dialysis in the United States.

R. Thadhani, F. Maddux, Kevin E. Chan, 2014, Journal of the American Society of Nephrology : JASN.

Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.

R. Thadhani, R. Hakim, J. Lazarus, 2009, Journal of the American Society of Nephrology : JASN.

Heritability of Risk for Sudden Cardiac Arrest in ESRD.

C. Newton-Cheh, J. Gusella, F. Maddux, 2015, Journal of the American Society of Nephrology : JASN.

The "right" of passage: surviving the first year of dialysis.

R. Hakim, J. Lazarus, R. Wingard, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Association of digoxin with mortality in ESRD: Does the medical evidence still apply when the patient is on dialysis?

R. Hakim, Kevin E. Chan, 2010 .

US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States.

N. Roetker, N. Powe, A. Israni, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

R. Thadhani, H. S. Warren, R. Hakim, 2012, Journal of the American Society of Nephrology : JASN.

Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis

E. Edelman, R. Thadhani, J. Wenger, 2015, Circulation.

A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors.

R. Thadhani, S. Nigwekar, J. Wenger, 2016, Journal of the American Society of Nephrology : JASN.

Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS.

S. Fukuhara, B. Gillespie, P. Komenda, 2013, Kidney international.

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

R. Thadhani, R. Hakim, J. Lazarus, 2009, Journal of the American Society of Nephrology : JASN.

Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease.

D. Steele, S. Nigwekar, Kevin E. Chan, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.

J. Piccini, R. Giugliano, M. Jardine, 2016, Journal of the American College of Cardiology.

Urinary Stone Disease and Cardiovascular Disease Risk in a Rural Chinese Population

Wei Zhang, Ying Sun, Xuemei Li, 2017, Kidney international reports.

Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis Patients

P. Kimmel, P. Eggers, K. Abbott, 2020, American Journal of Nephrology.

Digoxin associates with mortality in ESRD.

R. Hakim, J. Lazarus, Kevin E. Chan, 2010, Journal of the American Society of Nephrology : JASN.

Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients.

T. Ikizler, N. Brown, J. Gamboa, 2011, Kidney international.

US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States.

N. Roetker, N. Powe, A. Israni, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association between repeat hospitalization and early intervention in dialysis patients following hospital discharge.

R. Hakim, J. Lazarus, R. Wingard, 2009, Kidney international.

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease.

R. Thadhani, F. Maddux, Kevin E. Chan, 2013, Kidney international.

Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes.

R. Thadhani, R. Hakim, J. Lazarus, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Access survival amongst hemodialysis patients referred for preventive angiography and percutaneous transluminal angioplasty.

T. Ikizler, R. Hakim, D. Steele, 2011, Clinical journal of the American Society of Nephrology : CJASN.

International and Racial Differences in Mineral and Bone Disorder Markers and Treatments Over the First 5 Years of Hemodialysis in the Dialysis Outcomes and Practice Patterns Study

H. Morgenstern, F. Port, P. Csomor, 2019, Kidney medicine.

Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis

E. Edelman, R. Thadhani, J. Wenger, 2022 .

US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States

N. Powe, A. Israni, W. Winkelmayer, 2023, American Journal of Kidney Diseases.

Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

F. Maddux, Kevin E. Chan, J. Hymes, 2012, Journal of the American Society of Nephrology : JASN.

The "right" of passage: surviving the first year of dialysis.

R. Hakim, J. Lazarus, R. Wingard, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Warfarin, Atrial Fibrillation, and CKD: Effective and Safe, but Soon Extinct?

J. Larkin, Kevin E. Chan, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.